Development and characterisation of neutralising monoclonal antibody to the SARS-coronavirus

Journal of Virological Methods
Jody BerryFrank A Plummer

Abstract

There is a global need to elucidate protective antigens expressed by the SARS-coronavirus (SARS-CoV). Monoclonal antibody reagents that recognise specific antigens on SARS-CoV are needed urgently. In this report, the development and immunochemical characterisation of a panel of murine monoclonal antibodies (mAbs) against the SARS-CoV is presented, based upon their specificity, binding requirements, and biological activity. Initial screening by ELISA, using highly purified virus as the coating antigen, resulted in the selection of 103 mAbs to the SARS virus. Subsequent screening steps reduced this panel to seventeen IgG mAbs. A single mAb, F26G15, is specific for the nucleoprotein as seen in Western immunoblot while five other mAbs react with the Spike protein. Two of these Spike-specific mAbs demonstrate the ability to neutralise SARS-CoV in vitro while another four Western immunoblot-negative mAbs also neutralise the virus. The utility of these mAbs for diagnostic development is demonstrated. Antibody from convalescent SARS patients, but not normal human serum, is also shown to specifically compete off binding of mAbs to whole SARS-CoV. These studies highlight the importance of using standardised assays and reagents. These mAb...Continue Reading

References

Oct 1, 1995·The Journal of Cell Biology·D J OpsteltenP J Rottier
May 6, 2003·Science·Marco A MarraRachel L Roper
Aug 2, 2003·The New England Journal of Medicine·Gang LiAnlong Xu
Dec 4, 2003·Biochemical and Biophysical Research Communications·Xiaodong XiaoDimiter S Dimitrov
Mar 24, 2004·Nature Reviews. Microbiology·Konrad StadlerRino Rappuoli

❮ Previous
Next ❯

Citations

Oct 21, 2010·Virologica Sinica·Yu-xuan HouZheng-li Shi
Jun 12, 2012·Virologica Sinica·Wen-juan WangGuo-dong Liang
Nov 30, 2006·Immunology and Cell Biology·Yi-Hua ZhouSuzanne U Emerson
Aug 2, 2007·DNA and Cell Biology·Alexander N ZakhartchoukLorne A Babiuk
Apr 17, 2009·Canadian Journal of Microbiology·Shaun TylorRuntao He
Apr 22, 2014·Monoclonal Antibodies in Immunodiagnosis and Immunotherapy·Xin Yong YuanMa Luo
Aug 30, 2014·Monoclonal Antibodies in Immunodiagnosis and Immunotherapy·Akeel BaigCindi R Corbett
Mar 11, 2005·Emerging Infectious Diseases·Nigel J TempertonRobin A Weiss
Feb 17, 2009·Expert Opinion on Biological Therapy·Ponraj PrabakaranDimiter S Dimitrov
May 12, 2012·Journal of Virological Methods·Teresa M CabralCindi R Corbett
Nov 17, 2009·Journal of Immunological Methods·Janine D MullerLin-Fa Wang
Oct 18, 2005·Journal of Virological Methods·Yohannes BerhaneHana Weingartl
Sep 30, 2005·Vaccine·Deborah R Taylor
Mar 3, 2005·Antiviral Chemistry & Chemotherapy·Shiro Shigeta, Toshihiro Yamase
Apr 10, 2007·Virus Research·Luis EnjuanesRalph Baric
Jun 1, 2020·Current Protocols in Microbiology·Emelissa J MendozaMichael Drebot
Sep 24, 2020·Signal Transduction and Targeted Therapy·Fei YuShibo Jiang
Sep 29, 2020·SN Comprehensive Clinical Medicine·Nevio Cimolai
Sep 17, 2020·Clinical and Experimental Immunology·John S TregoningKatrina M Pollock
Nov 1, 2020·The Journal of Immunology : Official Journal of the American Association of Immunologists·Erik H VogelzangTheo Rispens
Aug 25, 2020·Asian Journal of Pharmaceutical Sciences·Yuefei ZhuZhiqing Pang
Jan 7, 2021·Nature Structural & Molecular Biology·Robert J EdwardsPriyamvada Acharya
Nov 17, 2020·SN Comprehensive Clinical Medicine·Nevio Cimolai

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA

Related Concepts

Related Feeds